ACADIAN ASSET MANAGEMENT LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2022$57
-99.9%
26,419
+32.3%
0.00%
Q2 2022$57,000
-72.6%
19,963
-53.3%
0.00%
-100.0%
Q2 2021$208,000
-54.5%
42,724
-58.4%
0.00%
-50.0%
Q1 2021$457,000
+41.9%
102,697
+23.7%
0.00%
+100.0%
Q4 2020$322,000
+19.7%
83,0520.0%0.00%0.0%
Q3 2020$269,000
-10.9%
83,052
+22.2%
0.00%0.0%
Q2 2020$302,000
+182.2%
67,964
+122.3%
0.00%
Q3 2019$107,00030,5760.00%
Other shareholders
ATYR PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tikvah Management LLC 1,225,833$9,157,0002.55%
Stonepine Capital Management, LLC 525,531$3,926,0001.80%
Telemetry Investments, L.L.C. 176,782$1,321,0001.70%
TANG CAPITAL MANAGEMENT LLC 1,113,453$8,317,0001.67%
VR Adviser, LLC 1,565,000$11,691,0001.60%
Deep Track Capital, LP 1,100,000$8,217,0000.58%
EAM Investors, LLC 252,280$1,885,0000.31%
EAM Global Investors LLC 152,792$1,141,0000.20%
FEDERATED HERMES, INC. 5,222,250$39,010,0000.07%
Alyeska Investment Group, L.P. 674,975$5,042,0000.06%
View complete list of ATYR PHARMA INC shareholders